Candida Infection Testing Market Report 2026

Candida Infection Testing Market Overview

• Candida Infection Testing market size has reached to $16.72 billion in 2025 • Expected to grow to $22.56 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Rising Yeast Infection Rates Drive Growth In Candida Testing Market • Market Trend: Technological Innovations In Candida Infection Testing • North America was the largest region in 2025.

What Is Covered Under Candida Infection Testing Market?

Candida infection testing refers to diagnostic procedures used to identify the presence of candida species, which are fungi that can cause infections in various parts of the body. These tests help determine the type and extent of the Candida infection, guiding appropriate treatment strategies. The main types of candida infection testing are invasive candidiasis and candidemia. Invasive candidiasis is a severe fungal infection that occurs when candida yeast enters the bloodstream and spreads throughout the body, affecting organs such as the heart, brain, eyes, bones, and other tissues. It also consists of various test types, including a vaginal pH test, nucleic acid amplification testing (NAAT), and a microbiome test, for various applications, including hospitals and laboratories.

What Is The Candida Infection Testing Market Growth Forecast?

The candida infection testing market size is expected to see strong growth in the next few years. It will grow to $22.56 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for rapid fungal diagnostics, rising adoption of molecular and microbiome testing, expansion of point-of-care fungal testing, growing investments in infectious disease diagnostics, increasing focus on personalized antifungal therapy. Major trends in the forecast period include increasing adoption of molecular candida detection methods, rising use of rapid naat-based testing, growing integration of microbiome analysis, expansion of hospital-based fungal diagnostics, enhanced focus on early fungal infection identification.

Global Candida Infection Testing Market Segmentation

1) By Type: Invasive Candidiasis, Candidemia 2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test 3) By Application: Hospital, Laboratory Subsegments: 1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing 2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing

What Is The Driver Of The Candida Infection Testing Market?

The increasing incidence of yeast infections is expected to propel the growth of the candida infection testing market going forward. Yeast infections refer to fungal infections caused by the overgrowth of candida, commonly affecting areas such as the mouth, genitals, and skin, and often resulting in itching, redness, and discomfort. Yeast infections are primarily caused by an overgrowth of the fungus candida, often due to imbalances in the body's natural bacteria, weakened immune systems, or hormonal changes. Candida infection testing is used in yeast infections to accurately diagnose the presence of candida overgrowth, helping healthcare providers confirm the infection and guide appropriate treatment. For instance, in May 2025, according to the UK Health Security Agency, a UK-based government public health agency, bloodstream infections caused by yeast in England rose by 4% in 2024 compared with 2023, increasing from 2,170 to 2,247 reports, and the rate increased from 3.8 to 3.9 per 100,000 population over the same period. Therefore, the increasing incidence of yeast infections will drive the growth of the candida infection testing industry.

Key Players In The Global Candida Infection Testing Market

Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

Global Candida Infection Testing Market Trends and Insights

Major companies operating in the candida infection testing market are focusing on developing technologically innovative solutions, such as a fully automated PCR rapid test for detecting candida, to enhance diagnostic accuracy and improve patient outcomes. A fully automated PCR rapid test for detecting candida refers to a high-tech diagnostic tool that uses polymerase chain reaction (PCR) technology to quickly and accurately identify the presence of Candida species in clinical samples. For instance, in May 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology manufacturer, launched a PCR test for candida auris detection on the Vivalytic platform, offering fully automated, rapid testing within an hour at the point of care. This advanced test allows for prompt screenings and contrasts sharply with traditional culture methods, which take one to three days in centralized labs, thus delaying diagnosis and treatment. Designed for clinical settings, the test is particularly beneficial for high-risk patients, enabling timely diagnosis and treatment to combat the serious health risks associated with C. auris infections.

What Are Latest Mergers And Acquisitions In The Candida Infection Testing Market?

In February 2024, Bruker Corporation, US-based scientific instruments and analytical solutions, announced the completion of its acquisition of ELITechGroup for approximately €870 million (around $942 million) in cash. The acquisition of ELITech by Bruker represents a strategic move to enhance its portfolio in molecular diagnostics and infectious disease testing. By integrating ELITech's innovative technologies and expertise. ELITechGroup France-based is a global leader in the in vitro diagnostics (IVD) industry.

Regional Outlook

North America was the largest region in the candida infection testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Candida Infection Testing Market?

The candida infection testing market includes revenues earned by entities by providing services such as diagnostic testing services, culture testing, consultation services, training and support, and microscopic examination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Candida Infection Testing Market Report 2026?

The candida infection testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the candida infection testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.